Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features.

Longxian Lv, Silan Gu, Huiyong Jiang, Ren Yan, Yanfei Chen, Yunbo Chen, Rui Luo, Chenjie Huang, Haifeng Lu, Beiwen Zheng, Hua Zhang, Jiafeng Xia, Lingling Tang, Guoping Sheng, Lanjuan Li
Author Information
  1. Longxian Lv: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  2. Silan Gu: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  3. Huiyong Jiang: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  4. Ren Yan: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  5. Yanfei Chen: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  6. Yunbo Chen: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  7. Rui Luo: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  8. Chenjie Huang: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  9. Haifeng Lu: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  10. Beiwen Zheng: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  11. Hua Zhang: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  12. Jiafeng Xia: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  13. Lingling Tang: Department of Infectious Diseases, Shulan (Hangzhou) Hospital, Affiliated to Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
  14. Guoping Sheng: Department of Infectious Diseases, Shulan (Hangzhou) Hospital, Affiliated to Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
  15. Lanjuan Li: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. ljli@zju.edu.cn. ORCID

Abstract

The relationship between gut microbes and COVID-19 or H1N1 infections is not fully understood. Here, we compared the gut mycobiota of 67 COVID-19 patients, 35 H1N1-infected patients and 48 healthy controls (HCs) using internal transcribed spacer (ITS) 3-ITS4 sequencing and analysed their associations with clinical features and the bacterial microbiota. Compared to HCs, the fungal burden was higher. Fungal mycobiota dysbiosis in both COVID-19 and H1N1-infected patients was mainly characterized by the depletion of fungi such as Aspergillus and Penicillium, but several fungi, including Candida glabrata, were enriched in H1N1-infected patients. The gut mycobiota profiles in COVID-19 patients with mild and severe symptoms were similar. Hospitalization had no apparent additional effects. In COVID-19 patients, Mucoromycota was positively correlated with Fusicatenibacter, Aspergillus niger was positively correlated with diarrhoea, and Penicillium citrinum was negatively correlated with C-reactive protein (CRP). In H1N1-infected patients, Aspergillus penicilloides was positively correlated with Lachnospiraceae members, Aspergillus was positively correlated with CRP, and Mucoromycota was negatively correlated with procalcitonin. Therefore, gut mycobiota dysbiosis occurs in both COVID-19 patients and H1N1-infected patients and does not improve until the patients are discharged and no longer require medical attention.

References

  1. Gut. 2017 Jun;66(6):1039-1048 [PMID: 26843508]
  2. J Mycol Med. 2020 Jun;30(2):100932 [PMID: 32008965]
  3. Science. 2020 Apr 24;368(6489):365-366 [PMID: 32327584]
  4. Hepatology. 2020 Feb;71(2):522-538 [PMID: 31228214]
  5. J Crohns Colitis. 2016 Mar;10(3):296-305 [PMID: 26574491]
  6. Cell Microbiol. 2015 Oct;17(10):1442-6 [PMID: 26243723]
  7. Gastroenterology. 2020 Jul;159(1):81-95 [PMID: 32251668]
  8. Nat Commun. 2018 Sep 10;9(1):3663 [PMID: 30202057]
  9. Nihon Kokyuki Gakkai Zasshi. 2011 Mar;49(3):226-31 [PMID: 21485158]
  10. Tuberculosis (Edinb). 2014 Jul;94(4):421-7 [PMID: 24863654]
  11. Int J Mol Sci. 2017 Mar 13;18(3): [PMID: 28335387]
  12. Environ Microbiol. 2020 Aug;22(8):3357-3374 [PMID: 32483901]
  13. Diagn Microbiol Infect Dis. 2011 Aug;70(4):492-8 [PMID: 20846815]
  14. Med Mycol. 2020 Apr 1;58(3):333-340 [PMID: 31309220]
  15. Patient Prefer Adherence. 2016 Apr 21;10:591-9 [PMID: 27143864]
  16. Ann Clin Microbiol Antimicrob. 2020 Jan 28;19(1):5 [PMID: 31992328]
  17. Chest. 2006 Jan;129(1):110-7 [PMID: 16424420]
  18. Cell Host Microbe. 2017 Dec 13;22(6):809-816.e4 [PMID: 29174402]
  19. Gastroenterology. 2020 Oct;159(4):1302-1310.e5 [PMID: 32598884]
  20. Front Cell Infect Microbiol. 2017 Sep 26;7:419 [PMID: 29018774]
  21. Sci Rep. 2020 Feb 27;10(1):3589 [PMID: 32108159]
  22. Lancet. 2020 Mar 28;395(10229):1054-1062 [PMID: 32171076]
  23. mBio. 2016 Sep 20;7(5): [PMID: 27651359]
  24. J Exp Med. 2014 Nov 17;211(12):2397-410 [PMID: 25366965]
  25. J Clin Virol. 2020 Jun;127:104364 [PMID: 32311650]
  26. Environ Int. 2016 Apr-May;89-90:71-80 [PMID: 26826364]
  27. Expert Rev Anti Infect Ther. 2020 Nov;18(11):1093-1103 [PMID: 32668993]
  28. Sci Rep. 2015 Oct 12;5:14600 [PMID: 26455903]
  29. Can Respir J. 2016;2016:2178218 [PMID: 27445521]
  30. Cell Host Microbe. 2018 Dec 12;24(6):847-856.e4 [PMID: 30503509]
  31. Gastroenterology. 2021 Mar;160(4):1050-1066 [PMID: 33347881]
  32. Gastroenterology. 2020 Jul;159(1):53-61 [PMID: 32353371]
  33. Emerg Microbes Infect. 2013 Jul;2(7):e44 [PMID: 26038477]
  34. Lancet. 2020 Jul 4;396(10243):63-70 [PMID: 32505220]
  35. J Clin Invest. 2017 Jun 30;127(7):2829-2841 [PMID: 28530644]
  36. Science. 2020 Jun 12;368(6496):1274-1278 [PMID: 32404477]
  37. Commun Biol. 2020 Nov 12;3(1):670 [PMID: 33184402]
  38. Nat Rev Microbiol. 2017 Jan;15(1):55-63 [PMID: 27694885]
  39. N Engl J Med. 2009 Dec 24;361(26):2507-17 [PMID: 20007555]
  40. Commun Biol. 2020 Oct 27;3(1):641 [PMID: 33110195]
  41. Bull World Health Organ. 2018 Feb 1;96(2):122-128 [PMID: 29403115]
  42. Clin Microbiol Rev. 2019 Feb 27;32(2): [PMID: 30814115]
  43. Biomed Pharmacother. 2021 Jan;133:110947 [PMID: 33197765]
  44. Cell Host Microbe. 2019 Mar 13;25(3):377-388.e6 [PMID: 30850233]
  45. Science. 2009 Jul 24;325(5939):484-7 [PMID: 19574347]
  46. Clin Microbiol Infect. 2020 Nov;26(11):1582-1584 [PMID: 32619736]
  47. Gastroenterology. 2020 Sep;159(3):944-955.e8 [PMID: 32442562]
  48. Clin Infect Dis. 2020 Dec 17;71(10):2669-2678 [PMID: 32497191]
  49. Gut. 2021 Feb;70(2):276-284 [PMID: 32690600]
  50. Nature. 2012 Jul 25;487(7408):477-81 [PMID: 22837003]
  51. BMJ. 2020 Apr 21;369:m1443 [PMID: 32317267]
  52. Virol J. 2015 Dec 12;12:215 [PMID: 26651485]
  53. Mediators Inflamm. 2020 Apr 4;2020:9560684 [PMID: 32322167]
  54. Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):331-345 [PMID: 30824884]
  55. Gastroenterology. 2020 May;158(6):1831-1833.e3 [PMID: 32142773]
  56. mSphere. 2017 Dec 13;2(6): [PMID: 29242837]

Grants

  1. 81800457/National Natural Science Foundation of China (National Science Foundation of China)
  2. 81570512/National Natural Science Foundation of China (National Science Foundation of China)
  3. LED20H190001/Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation)
  4. LQ19H030007/Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation)

MeSH Term

Adult
Aged
Bacteria
COVID-19
Dysbiosis
Feces
Female
Fungi
Gastrointestinal Microbiome
Humans
Influenza A Virus, H1N1 Subtype
Influenza, Human
Male
Middle Aged
SARS-CoV-2
Sequence Analysis, DNA

Word Cloud

Created with Highcharts 10.0.0patientsCOVID-19correlatedmycobiotaH1N1-infectedgutAspergilluspositivelyH1N1infectionsHCsassociationsclinicalfeaturesdysbiosisfungiPenicilliumMucoromycotanegativelyCRPrelationshipmicrobesfullyunderstoodcompared673548healthycontrolsusinginternaltranscribedspacerITS3-ITS4sequencinganalysedbacterialmicrobiotaComparedfungalburdenhigherFungalmainlycharacterizeddepletionseveralincludingCandidaglabrataenrichedprofilesmildseveresymptomssimilarHospitalizationapparentadditionaleffectsFusicatenibacternigerdiarrhoeacitrinumC-reactiveproteinpenicilloidesLachnospiraceaemembersprocalcitoninThereforeoccursimprovedischargedlongerrequiremedicalattentionGutalterations

Similar Articles

Cited By